Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengming Liu

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Cell Death & Disease|October 31, 2020
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancerYuanyuan Lei, Zhiliang Lu, Jianbing Huang, et al.
Frontiers in Veterinary Science|December 10, 2024
Integrated transcriptomic and metabolomic analyses reveal heterosis for meat quality of Neijiang pigsHaifeng Dan, Chengming Liu, Huiling Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 22, 2020
Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancerShuangshuang Mao, Zhiliang Lu, Sufei Zheng, et al.
BMC Medicine|July 26, 2022
Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Translational Lung Cancer Research|August 25, 2021
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1Shuangshuang Mao, Sufei Zheng, Zhiliang Lu, et al.
Journal of Translational Medicine|January 1, 2020
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificityRuochuan Zang, Xinfeng Wang, Runsen Jin, et al.
BMC Medicine|May 13, 2022
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Cancer Medicine|April 2, 2019
PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicingShuangshuang Mao, Yuan Li, Zhiliang Lu, et al.
Frontiers in Oncology|February 28, 2022
The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase InhibitorsGuangjian Yang, Chengming Liu, Jiaqi Hu, et al.
Cancer Communications (London, England)|July 11, 2022
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancerChengming Liu, Sufei Zheng, Zhanyu Wang, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|October 31, 2020
The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancerYuanyuan Lei, Zhiliang Lu, Jianbing Huang, et al.
Frontiers in Veterinary Science|December 10, 2024
Integrated transcriptomic and metabolomic analyses reveal heterosis for meat quality of Neijiang pigsHaifeng Dan, Chengming Liu, Huiling Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 22, 2020
Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancerShuangshuang Mao, Zhiliang Lu, Sufei Zheng, et al.
BMC Medicine|July 26, 2022
Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Translational Lung Cancer Research|August 25, 2021
Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1Shuangshuang Mao, Sufei Zheng, Zhiliang Lu, et al.
Journal of Translational Medicine|January 1, 2020
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificityRuochuan Zang, Xinfeng Wang, Runsen Jin, et al.
BMC Medicine|May 13, 2022
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Cancer Medicine|April 2, 2019
PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicingShuangshuang Mao, Yuan Li, Zhiliang Lu, et al.
Frontiers in Oncology|February 28, 2022
The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase InhibitorsGuangjian Yang, Chengming Liu, Jiaqi Hu, et al.
Cancer Communications (London, England)|July 11, 2022
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancerChengming Liu, Sufei Zheng, Zhanyu Wang, et al.
Pageof 7